Toxoplasma gondii is an obligate intracellular parasite that can cause severe neurological disease in infected humans. CD40 is a receptor on macrophages that plays a critical role in controlling T. gondii infection. We examined the regulation of CD40 on the surface of T. gondii-infected bone marrow-derived macrophages (BMdMs). T. gondii induced CD40 expression both at the transcript level and on the cell surface, and interestingly, the effect was parasite strain specific: CD40 levels were dramatically increased in type II T. gondii-infected BMdMs compared to type I-or type III-infected cells. Type II induction of CD40 was specific to cells harboring intracellular parasites and detectable as early as 6 h postinfection (hpi) at the transcript level. CD40 protein expression peaked at 18 hpi. Using forward genetics with progeny from a type II ؋ type III cross, we found that CD40 induction mapped to a region of chromosome X that included the gene encoding the dense granule protein 15 (GRA15). Using type I parasites stably expressing the type II allele of GRA15 (GRA15 II ), we found that type I
T oxoplasma gondii is an obligate intracellular parasite and the causative agent of toxoplasmosis. An estimated 30% of the world population is infected with this protozoan parasite (1) . Acute infection with T. gondii is characterized by proliferation and dissemination of the fast-growing tachyzoite form of the parasite, followed by encystment of the parasite as slow-growing bradyzoites that establish a persistent chronic infection for the duration of the host's lifetime.
A robust innate immune response is initiated rapidly following T. gondii infection and is responsible for establishing a first line of defense. Myeloid cells, such as monocytes, dendritic cells, and macrophages, are among the first immune cells to migrate to the site of infection and subsequently become activated (2) . CD40 is a cell surface receptor that plays a pivotal role in macrophage activation and parasite immunity. The engagement between CD40 and CD40L (CD154), expressed by antigen-presenting cells (APCs) and activated CD4 ϩ T cells, respectively, results in the establishment of antimicrobial programs that contribute to enhanced in vivo control against a number of pathogens (3, 4) , including T. gondii (5, 6) . CD40 engagement on macrophages leads to the production of nitric oxide (NO) (7) and the induction of autophagy (8) , both of which limit the survival of intracellular pathogens. In the case of T. gondii infection, CD40 establishes an antimicrobial program that contributes to parasite control independently of other established gamma interferon (IFN-␥)-and p47 GTPase-dependent mechanisms of defense (6, 9) . CD40 engagement has long been known to result in interleukin-12 (IL-12) production (10) (11) (12) , which is critical for parasite control. IL-12 is produced by activated APCs shortly after T. gondii infection (13, 14) and is necessary for priming adaptive immunity (15) . CD40 induction of IL-12 leads to the release of IFN-␥ (16), a key mediator of host resistance during T. gondii infection (17) . In addition, since T cells are crucial for controlling T. gondii infection (18, 19) , disruption of sustained IL-12 production diminishes Th1 immune responses and promotes parasite growth and dissemination.
Although CD40 plays a critical role in host defense against T. gondii and is induced during infection (5, 20) , how this receptor is regulated during parasite infection remains unknown. Lipopolysaccharide (LPS) stimulation of macrophages and microglia has been shown to induce CD40 transcription via STAT-1 and NF-B p65 and p50 nuclear translocation and binding to the CD40 promoter (21) . In addition to NF-B, binding of the transcription factor specificity protein 1 (Sp1) to the CD40 promoter was necessary for optimal CD40 induction in response to LPS (22) . STAT-1 signaling was found to be critical for CD40 expression following IFN-␥ stimulation (23) , whereas IL-4 inhibits CD40 expression through STAT6 signaling (24) . We examined how CD40 is regulated during T. gondii infection. We found that CD40 is induced in a strain-specific manner and that the type II parasite dense granule protein 15 (GRA15) is sufficient for CD40 induction in macrophages through NF-B signaling. Moreover, en-gagement of CD40 with CD40L resulted in enhanced IL-12 responses in macrophages infected with a type II strain of T. gondii.
MATERIALS AND METHODS
Mammalian and parasite cell culture. Human foreskin fibroblasts (HFFs) and human embryonic kidney 293T (293T) Phoenix-E cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific, Logan, UT) supplemented with 10% heat-inactivated fetal calf serum (FCS; HyClone, Logan, UT), 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (D-10% medium). Bone marrowderived macrophages (BMdMs) from C57BL/6 mice were generated as previously described (25) and cultured in D-10% medium supplemented with 10% macrophage colony-stimulating factor for 5 days. Cells were then seeded overnight before T. gondii infection assays. Splenocytes were isolated from C57BL/6 mice as described previously (26) . THP-1 cells were cultured in R-10% medium, consisting of RPMI 1640 (Thermo Fisher Scientific, Logan, UT) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. Where indicated, THP-1 cells were stimulated with 5 mM phorbol myristate acetate (PMA) for 24 h, washed, and then cultured in fresh R-10% medium for an additional 24 h.
T. gondii tachyzoites of type I (RHgfpluc [27] ), type II (ME49fLuc; generously provided by John Boothroyd), and type III (C⌬Luc123 [28] ) and transgenic type I tachyzoites stably expressing the type II allele of GRA15 (type I GRA15 II ) (29) were used for infection of BMdMs. All parasite strains constitutively expressed green fluorescent protein (GFP) and were maintained by serial passage in confluent HFF monolayers as previously described (30) .
All mammalian and parasite cell cultures were maintained in incubators set at 37°C with 5% CO 2 . Cell lines and parasite strains were tested monthly for Mycoplasma contamination and confirmed to be negative. All research involving mice was carried out in compliance with the Institutional Animal Care and Use Committee at the University of California, Irvine (UCI).
Antibodies and flow cytometry. BMdMs, PMA-stimulated THP-1 cells, and THP-1 cells transduced with hemagglutinin (HA)-tagged GRA15 (THP-1ϩGRA15 II -HA) were resuspended in fluorescence-activated cell sorting (FACS) wash (phosphate-buffered saline [PBS] with 2% FCS) containing anti-Fc receptor antibody (for mouse, clone 2.4G2 [BD Biosciences, San Jose, CA]; for human, human Fc receptor binding inhibitor [eBioscience, San Diego, CA]) and incubated on ice for 10 min. For cell surface marker staining, all antibodies were resuspended in FACS wash. BMdMs were pelleted by centrifugation, stained with biotinylated control Ig or biotinylated anti-mouse CD40 (clone 3/23; BioLegend, San Diego, CA) on ice for 30 min, and then stained with streptavidin-phycoerythrin (PE) on ice for 15 min. Splenocytes were stained with anti-mouse CD19-PE-cyan 7 (Cy7) (clone 6D5; BioLegend), anti-mouse CD11c-PECy7 (clone N418; BioLegend), or anti-mouse CD40-allophycocyanin (APC) (clone 3/23; BioLegend). Human THP-1 cells were stained with anti-human CD40-PE (clone 5C3; BioLegend) or a mouse IgG1-PE control antibody. After the final wash, the cells were fixed with 4% paraformaldehyde (PFA) prior to analysis by flow cytometry.
All flow cytometry samples were examined using a FACSCalibur cytometer with CellQuest software (BD Biosciences, San Jose, CA) for acquisition and FlowJo software (Tree Star, Ashland, OR) for analysis. For the mock-treated cells, the histograms depict the total cell population. Since GFP-expressing T. gondii parasites were used for the infection and flow cytometry experiments, the histograms for the infected cells depict those cells that fell within the GFP-positive (GFP ϩ ) gate. Gene expression analysis by qPCR. BMdMs from C57BL/6 mice were infected as described above. At 6 h postinfection (hpi), RNA was harvested using an RNeasy kit (Qiagen, Germantown, MD) and treated with DNase I (Invitrogen, Carlsbad, CA). cDNA was generated and used as the template in real-time quantitative PCR (qPCR) with primers specific for mouse CD40: forward primer 5=-GCTATGGGGCTGCTTGTTGA-3= and reverse primer 5=-ATGGGTGGCATTGGGTCTTC-3=. Mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used for normalization using the following primers: forward primer 5=-GCATGGCCTT CCGTGTTC-3= and reverse primer (5=-GATGTCATCATACTTGGCAG GTTT-3=. qPCR was performed in triplicate using a Bio-Rad iCycler apparatus and iTaq Universal SYBR green Supermix (Bio-Rad, Hercules, CA).
The data from the qPCR were analyzed using the threshold cycle (2 Ϫ⌬⌬CT ) method (31) . The values obtained for CD40 expression were normalized to those for GAPDH expression, and the data are expressed as the ratio of mRNA levels. Error bars reflect the standard deviation from triplicate samples. In all qPCR assays, cDNA generated in the absence of reverse transcriptase was used as a negative control to detect contaminating genomic DNA. No amplification was observed in the samples tested in the absence of reverse transcriptase or in samples containing water in the place of DNA template.
QTL mapping. CD40 mean fluorescence intensity values generated from BMdMs infected with 19 F1 progeny derived from crosses between a type II strain and a type III strain (28, 32) were analyzed using R/qtl software (33) and the existing T. gondii genetic map (34) . Quantitative trait locus (QTL) peaks were identified using the marker regression method (mr). The overall significance level was determined using 1,000 permutations of the genotype data.
NF-B inhibitor assay. BMdMs were cultured for 24 h in medium treated with dimethyl sulfoxide (DMSO) as a vehicle control or with the IB kinase (IKK) inhibitor PS1145 (Sigma-Aldrich, St. Louis, MO) (35) . The concentration used was selected based on the findings of dose-response experiments that we performed to select the lowest concentration that showed specific effects on the target (data not shown). After 24 h, the medium was replaced with untreated macrophage medium and the cells were mock infected or infected with type I or type I GRA15 II T. gondii parasites. At 1 hpi, the cells were washed and the medium was replaced with fresh macrophage medium or macrophage medium supplemented with DMSO or PS1145. The cells were harvested at 18 hpi for antibody staining and flow cytometry analysis for CD40 expression.
Retroviral transduction.
The open reading frame (ORF) for T. gondii type II GRA15 (GRA15 II ) with a C-terminal HA epitope tag was cloned into the BamHI and EcoRI sites of the pMX-puro retroviral vector to generate the vector IP9. This construct was generated by performing nested primer PCR using the following primers: forward primer GRA15-BamHI (5=-GCTTCAGGATCCATGATAATTCGGTGGCTTGGGTATC TTACGG-3=), reverse primer 1 (primer GRA15-HA; 5=-TCTGGGACGTC GTATGGGTATGGAGTTACCGCTGATTGTGTGTCCC-3=), and reverse primer 2 (primer GRA15-HA-EcoRI; 5=-GTAATGGAATTCTCAAGCGTA GTCTGGGACGTCGTATGGGTATGGAGTTA-3=). Phoenix-E packaging cells were transfected with IP9 (GRA15 II -HA-pMX-puro) or the parental pMX-puro plasmid as a negative control using the Lipofectamine 2000 reagent (Life Technologies, Carlsbad, CA) according to the manufacturer's protocol. Retroviral supernatants were harvested on days 2 and 3 posttransfection and centrifuged at 1,200 rpm for 10 min to clarify the supernatant and remove cell debris. THP-1 cells were infected with the retrovirus by centrifugation at 2,500 rpm for 2 h at 25°C in the presence of 8 g/ml hexadimethrine bromide (Sigma-Aldrich, St. Louis, MO). At 40 h postinfection, the transduced cells were placed in selection medium containing 2 g/ml puromycin (Thermo Fisher Scientific, Logan, UT). Western blotting was performed after 5 days in puromycin selection medium to confirm the expression of GRA15 II -HA.
Western blotting. Transduced THP-1 cells were washed with ice-cold 1ϫ PBS, and cell lysates were generated by the addition of 2ϫ Laemmli sample buffer containing 10% ␤-mercaptoethanol. The lysates were separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes for immunoblotting. The membranes were blotted with a horseradish peroxidase (HRP)-conjugated antibody against the HA epitope tag (Cell Signaling, Danvers, MA). The membranes were devel-oped with the Amersham ECL Prime reagent (GE Healthcare, Waukesha, WI) and detected using a Nikon camera, as previously described (36) .
Transient transfection. 293T cells were used to generate CD40L-expressing transfectants (293T-CD40L). 293T cells were transfected with the CD40L-MIEG-hCD4 plasmid containing the complete coding sequence for the murine CD40L (plasmid 40355; Addgene, Cambridge, MA) using Lipofectamine 2000 (Life Technologies, Carlsbad, CA) according to the manufacturer's protocol. To generate control cells, the parental 293T cells were treated with Lipofectamine 2000 in the absence of plasmid. The control 293T cells and CD40L-expressing 293T cells were cultured for 48 h at 37°C before addition to the BMdMs for the coculture experiments.
CD40L stimulation assays. At day 6 of culture, the BMdMs were mock infected or infected with type I, type II, or type I GRA15 II parasites, as described above. At 18 hpi, 293T or CD40L-expressing 293T cells were added to BMdMs at a ratio of 1:2 (293T cells/BMdMs) without changing the medium. At 26 hpi, the cell culture supernatants were collected to measure IL-12p70 by enzyme-linked immunosorbent assay (ELISA) (BioLegend, San Diego, CA).
Statistical analysis. Unless otherwise indicated, an unpaired, twotailed Student's t test was used to determine statistical significance. Differences were considered significant when P was Ͻ0.05.
RESULTS
Type II T. gondii induces high levels of CD40 on infected macrophages. We evaluated the expression of the costimulatory molecule CD40 on macrophages following T. gondii infection. After infecting primary mouse BMdMs with types I, II, or III parasites, we observed that CD40 transcript levels were increased in all infected samples at 6 hpi. However, the increase in CD40 transcript levels was significantly higher in BMdMs infected with type II parasites than in mock-infected cells (10-fold change, P Ͻ 0.05) or cells infected with either type I or III parasites (Fig. 1A) . We then investigated whether there was a strain-specific induction of CD40 on the surface of infected cells. Flow cytometry analysis of infected BMdMs at 18 hpi revealed that the highest induction of CD40 was observed in cells infected with the type II strain (Fig. 1B) . Moreover, CD40 was specifically upregulated in the infected, GFP ϩ population, and the cells with the highest level of GFP had the strongest CD40 upregulation. To examine whether infection induces CD40 in other types of immune cells, cultures of splenocytes harvested from C57BL/6 mice were infected with type II T. gondii parasites and CD40 was modestly induced on the infected CD19 ϩ (B cell) and CD11c ϩ (dendritic cell) populations (see Fig. S1 in the supplemental material). We next investigated the kinetics of CD40 induction following infection with the type II strain of T. gondii. CD40 cell surface protein levels were increased by 12 hpi and peaked at 18 hpi in T. gondii-infected BMdMs compared to their levels in mock-infected cells (Fig. 1C) . These data indicate that T. gondii induced CD40 expression on infected macrophages and that a high level of CD40 induction occurred in a parasite strain-specific manner. The observation that the high level of CD40 induction was strain specific suggested the possibility of a genetic basis for the phenotype. In this case, the phenotype should segregate among recombinant progeny generated by a cross between the type II and either the type I or type III parental strains. Indeed, by comparing CD40 levels on macrophages infected with type II ϫ type III recombinant progeny lines, we found that some strains induced high CD40 levels, whereas other strains induced CD40 at a low level (see Table S1 in the supplemental material). We analyzed CD40 levels in BMdMs infected with 19 F1 recombinant progeny and used QTL mapping to identify the genetic locus responsible for this effect. QTL mapping identified three peaks on chromosomes Ia, VIIb, and X ( Fig. 2A) . The presence of more than one peak suggests that the CD40-inducing phenotype is a multilocus trait. Although the peak observed on the right arm of chromosome X (logarithm of odds score ϭ 2.87; P ϭ 0.145) was not statistically significant, we chose to further investigate this genetic region since it showed the strongest association with the phenotype of high CD40 induction. To do this, we chose two strains from the original 19 F1 recombinant progeny as well as two additional strains (S26 and S28 [28] ) that had recombinations in the right arm of chromosome X for more detailed analysis. Using the annotated genotype maps for these four strains (28), we found that strains with the type II genotype between marker AK157 and the end of chromosome X induced high levels of CD40 expression, whereas those with the type III genotype had low levels of CD40 induction (Fig. 2B) . Specifically, CL13 and S30 did not induce high levels of CD40 (Fig. 2B ) and strain S28 also only weakly upregulated CD40 expression; however, strain S26 induced the high CD40 expression phenotype (Fig. 2B) . The responsible 0.46-megabase region of chromosome X contains 91 genes, 31 of which encode putative secretory proteins, including GRA15 (29) .
GRA15 II induces CD40 on infected macrophages. To test if GRA15 mediates CD40 induction in macrophages infected with the type II strain, we infected BMdMs with type I or type II parasites or type I parasites expressing the type II allele of GRA15 (called type I GRA15 II ). As expected, type I parasites did not induce robust CD40 cell surface expression on infected BMdMs. In contrast, the expression of CD40 was increased on cells infected with type I GRA15 II and type II parasites (Fig. 3A) . To evaluate if human macrophage-like cells upregulate CD40 following infection with type I, type II, or type I GRA15 II parasites, THP-1 cells differentiated with phorbol myristate acetate (PMA) were infected with each of these three parasite strains. Similar to murine macrophages, human THP-1 differentiated macrophages were found to increase CD40 expression after infection with either type II or type I GRA15 II parasites but not with type I parasites (Fig. 3B) .
Recent work demonstrated that the protein encoded by the type II allele of GRA15 (GRA15 II ) mediates sustained NF-B nuclear translocation in T. gondii-infected cells (29) and induces the production of IL-12 in mouse macrophages (29) and IL-1␤ in human monocytes (30) . Additionally, NF-B signaling has been found to play a role in LPS-induced CD40 expression in macrophages (21) . To evaluate if GRA15 II -induced CD40 expression was NF-B dependent, we analyzed CD40 levels on type I GRA15 II parasite-infected BMdMs treated with the IB kinase (IKK) inhibitor PS1145 (35) . Infection with type I GRA15 II parasites resulted in CD40 upregulation in untreated macrophages or DMSOtreated macrophages, as expected. However, CD40 expression on BMdMs treated with the NF-B inhibitor was markedly reduced compared to that on untreated or vehicle control-treated cells (Fig. 4) . These data indicate that GRA15 II mediates the induction of CD40 in both infected human THP-1 cells and mouse macrophages and that NF-B signaling contributes to this induction.
GRA15 II is sufficient for T. gondii-induced CD40 expression. To evaluate if GRA15 II alone is sufficient to induce CD40 expression in the absence of parasite infection, we generated a retroviral vector containing the cDNA of the GRA15 II allele fused to the sequence for the HA epitope tag. THP-1 cells were stably transduced with this vector (GRA15 II -HA) or the parental pMX-puro vector (pMX-puro) as a control. We confirmed the expression of the HA-tagged GRA15 II by Western blotting (Fig. 5A) . Expression of GRA15 II -HA in THP-1 cells was sufficient to induce the expression of CD40, even in the absence of parasite infection (Fig. 5B) .
CD40 expression on infected macrophages enhances IL-12 production following CD40L stimulation. In addition to their role as professional APCs, macrophages are capable of eliciting cell-intrinsic effector functions through CD40 signaling. For example, CD40 and CD40L engagement has been shown to induce the transcription and secretion of IL-12p40 (37) . Since CD40 levels are upregulated on macrophages infected with type II parasites, we hypothesized that type II-infected cells may have enhanced CD40-mediated effector functions. To investigate this possibility, we measured the production of the biologically active IL-12p70 heterodimer by BMdMs that were mock infected or infected with type I, type II, or type I GRA15 II parasites for 18 h and then cultured with 293T cells or with 293T cells expressing murine CD40L for an additional 8 h. The level of production of IL-12p70 by mock-infected and type I-infected BMdMs was below the level of detection, regardless of whether the cells were cultured with control 293T cells or CD40L-expressing 293T cells (Fig. 6 ). In contrast, infection of BMdMs with the type II or type I GRA15 II parasites resulted in the production and secretion of IL-12p70 when cultured alone or with 293T cells. Notably, culturing BMdMs infected with the type II or type I GRA15 II parasites with CD40L-expressing 293T cells resulted in a significant increase in the pro- duction of IL-12p70. These data suggest that the engagement of CD40 on macrophages infected with type II T. gondii contributes to the elevated production of IL-12 in response to interaction with CD40L.
DISCUSSION
The establishment of host defense against infection with T. gondii is initiated by cells of the innate immune response, which help to shape the course of the infection. Effective parasite control requires a robust immune response without the induction of immunopathology. This is achieved through coordinated communication between innate immune cells and the regulation of signaling cascades triggered by cell surface immune receptors. The modulation of immune receptors on macrophages during the acute stage of infection can have profound implications for the development of the ensuing immune response. This led us to investigate the mechanisms behind the observed induction of CD40 on infected macrophages following infection with T. gondii. It has previously been shown that CD40 is upregulated on mouse macrophages (5) and human monocytes (20) after T. gondii infection. We found that there is a parasite strain specificity to this induction: the type II strain of T. gondii induced high levels of expression of CD40, whereas the types I and III strains induced only low levels of CD40 expression. The protein encoded by the GRA15 II allele drove CD40 expression in a NF-B-dependent manner. Furthermore, we showed that the induction of CD40 in cells infected with parasites expressing GRA15 II contributed to the establishment of a Th1-conducive microenvironment through the production of IL-12p70 after stimulation with CD40L. By investigating the mechanism of CD40 induction by the type II strain of T. gondii, we have identified a parasite factor that contributes to CD40 induction and found a role for infected cells in the establishment of protective immunity during parasite infection.
CD40 and CD40L engagement contributes to enhanced parasite clearance through the activation of macrophages and other APCs (38) . CD40/CD40L interaction leads to the induction of an antimicrobial program in macrophages (8, 39) and is also critical for controlling T. gondii infection in mice (5). This results in a reduction in the T. gondii burden in infected cells (9, 40) . Despite the elevated levels of CD40 on type II-infected macrophages, we did not observe a strain-specific enhancement in parasite clearance in these cells due to CD40 signaling (data not shown). CD40 engagement also leads to the production of IL-12, tumor necrosis factor alpha, and nitric oxide, which have been shown to play key roles in host defense (11, 12, 41, 42) . These cytokines and effectors produced in response to CD40 engagement are important for establishing an immune response capable of controlling intracellular pathogens through Th1-mediated immunity (3, 4) . CD40 signal strength can profoundly affect p38 and extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) signaling and IL-12 production (12, 43, 44) , as well as T cell skewing through reciprocal regulation of IL-12 and IL-4 (15, 45) . We demonstrate that macrophages infected with CD40-inducing T. gondii parasite strains dramatically increase IL-12 production following CD40-CD40L stimulation: type II-infected macrophages cultured with CD40L-expressing cells exhibited a more than 12-fold increase in IL-12p70 production compared to type II-infected cells that were cultured with the control cells. The enhanced CD40 expression may amplify the strength of the signal mediated by CD40L stimulation. Consistent with our findings, it is known that strong CD40 engagement, achieved by increasing the concentration of recombinant soluble CD40L, results in robust Th1-skewing conditions due to preferential p38 signaling and subsequently more IL-12p40 and p70 production (44) . In contrast, weak CD40 engagement of T cells was found to enhance Th2 immunity due to elevated ERK activation and subsequently enhanced IL-10 expression (44). Our observation that type II T. II  II  II  II  II  III  III  III  III  III  III  III  III  III  III  III  III  III  III  II  II  II  II  II  II  II  II  II  II  III  III  III  III  II  II  II  II  II  II  III  III  III  III gondii-infected macrophages produce higher levels of IL-12p40 following CD40 engagement suggests that these infected cells contribute to the promotion of Th1 responses.
T. gondii proteins secreted into infected host cells have been shown to alter host cell signaling and gene transcription (46) (47) (48) as well as antimicrobial processes (49) (50) (51) . Interestingly, however, there are parasite strain-specific effects on the modulation of host cell signaling pathways, including the JAK/STAT, NF-B, and MAPK pathways. A growing body of work has demonstrated that the differences in the modulation of these host cell signaling pathways are a result of strain-specific polymorphisms in the secreted factors released into host cells during infection (48, (52) (53) (54) . Consequently, polymorphisms in secreted parasite proteins can differentially influence macrophage polarization and effector functions: type I parasites induce an alternative activation state, whereas type II strains induce a classical activation state (55) . Type I T. gondii parasites actively dampen the responsiveness of infected host cells by directly activating STAT3 signaling, rendering cells refractory to IFN-␥ stimulation (51). Lang et al. demonstrated that the suppressed responsiveness to IFN-␥ is the result of chromatin remodeling following infection with the type I RH strain of T. gondii (47) . Our data showing CD40 upregulation by the type II strain of T. gondii are consistent with this paradigm, and CD40 upregulation primes macrophages for a proinflammatory program following receptor engagement (45, 55) .
The pathways that mediate CD40 induction after T. gondii infection were unknown. The fact that CD40 was induced in a strain-specific manner enabled us to use QTL analysis to identify a genomic region that associates with CD40 induction. QTL analysis indicated that the genomic locus responsible for CD40 induction contained the gene GRA15 (TGME49_275470), which encodes the dense granule protein GRA15. GRA15 was the first T. gondii dense granule protein shown to modulate host cell NF-B signaling due to sustained nuclear translocation of p65 (29) . The GRA15 allele of type II T. gondii encodes a protein consisting of 635 amino acids, while the GRA15 allele of type I parasites contains a frameshift mutation that leads to a premature stop codon and a final protein product of 312 amino acids. Additionally, the type I and type III alleles of GRA15 contain an insertion/deletion mutation near the C terminus of the protein, along with 5 other amino acids that are polymorphic (29) . We demonstrate that GRA15 II is sufficient to induce CD40 expression even in the absence of parasite infection.
Surprisingly, we observed that not all type II strains induce CD40 expression. Whereas infections with independently obtained ME49 strains highly upregulated CD40, the Prugniaud strain (56) did not (see Fig. S2 in the supplemental material). It has previously been reported that there are phenotypic differences between different type I lines (57) were partially explained by polymorphisms in GRA15 (57) . Sequence analysis of the GRA15 coding sequence for the ME49 and Prugniaud strains revealed that they were 100% identical (data not shown), whereas analysis of the genomic region upstream of the GRA15 transcription start site revealed the presence of a 2-nucleotide insertion in the Prugniaud strain. The significance of these additional nucleotides has yet to be determined. One possible explanation for the observed differences in CD40 induction between type II parasite isolates is that CD40 expression is regulated by additional parasite factors that differ in function or expression level between the type II strains that we have evaluated. CD40 expression induced by the various recombinant progeny was not strictly binary, suggesting that while CD40 induction is primarily dependent on GRA15, it is likely to be influenced by additional parasite factors. Indeed, QTL analysis revealed the presence of an additional peak on chromosome Ia and on chromosome VIIb ( Fig. 2A ). There is a precedent for the dual regulation of host pathways by secreted proteins, such as ROP5 and ROP18. Strain differences in the parasites' susceptibility to killing by IFN-␥-stimulated mouse embryonic fibroblasts were dependent on the expression of both virulent polymorphic genes encoding ROP5 E. L. and ROP18 J. A. (48) . In addition, the protein encoded by the virulent allele of ROP16 in type I parasites has been shown to antagonize the activity of GRA15 (29) . Further work characterizing additional parasite factors that enhance or inhibit GRA15 activity may help to explain the differences in CD40 induction observed in distinct type II isolates.
Here we report a novel function for GRA15 in CD40 induction and demonstrate that CD40 signaling amplifies the IL-12 response in type II-infected macrophages and may contribute to the Th1 environment established during infection with type II strains of T. gondii. 
